Matinas BioPharma Holdings, Inc.
MTNB
$0.62
$0.0294.91%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.43M | -4.28M | -5.72M | -5.82M | -5.31M |
| Total Depreciation and Amortization | 247.00K | 244.00K | 241.00K | 240.00K | 240.00K |
| Total Amortization of Deferred Charges | -17.00K | -- | -18.00K | 18.00K | 107.00K |
| Total Other Non-Cash Items | 4.61M | 968.00K | 972.00K | 995.00K | 1.18M |
| Change in Net Operating Assets | 86.00K | -437.00K | 1.42M | -1.20M | -795.00K |
| Cash from Operations | -3.51M | -3.50M | -3.11M | -5.77M | -4.58M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 500.00K | 9.65M | -2.94M | 2.00M | 2.96M |
| Cash from Investing | 500.00K | 9.65M | -2.94M | 2.00M | 2.96M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.00K | -2.00K | -1.00K | -1.00K | -1.00K |
| Issuance of Common Stock | 0.00 | -- | 9.19M | 54.00K | -- |
| Repurchase of Common Stock | -- | -65.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.00K | -67.00K | 9.19M | 53.00K | -1.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.01M | 6.08M | 3.15M | -3.72M | -1.62M |